These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12767688)

  • 41. Studies on the maintenance of cytochromes P-450 and b5, monooxygenases and cytochrome reductases in primary cultures of rat hepatocytes.
    Grant MH; Melvin MA; Shaw P; Melvin WT; Burke MD
    FEBS Lett; 1985 Oct; 190(1):99-103. PubMed ID: 4043400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repeated oral benzene exposure alters enzymes involved in benzene metabolism.
    Daiker DH; Moslen MT; Carr JB; Ward JB
    J Toxicol Environ Health; 1996 Aug; 48(5):439-51. PubMed ID: 8751834
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of glutathione on the catalytic activity of reconstituted cytochrome P450 3A4.
    Kim BR; Kim DH
    Biochem Biophys Res Commun; 1998 Jan; 242(1):209-12. PubMed ID: 9439637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alterations of heme, cytochrome P-450, and steroid metabolism by mercury in rat adrenal.
    Veltman JC; Maines MD
    Arch Biochem Biophys; 1986 Aug; 248(2):467-78. PubMed ID: 2943220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biological monitoring of exposure to benzene: a comparison between S-phenylmercapturic acid, trans,trans-muconic acid, and phenol.
    Boogaard PJ; van Sittert NJ
    Occup Environ Med; 1995 Sep; 52(9):611-20. PubMed ID: 7550802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biomarkers of human exposure to benzene.
    Bechtold WE; Henderson RF
    J Toxicol Environ Health; 1993; 40(2-3):377-86. PubMed ID: 8230308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The roles of cytochrome b5 in reconstituted monooxygenase systems containing various forms of hepatic microsomal cytochrome P-450.
    Imai Y
    J Biochem; 1981 Feb; 89(2):351-62. PubMed ID: 6972374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes.
    Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF
    Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure and expression of genes coding for components of the cytochrome P-450-mediated mono-oxygenase.
    Shephard EA; Phillips IR; Ashworth A; Ferrie JS; Forrest LA; Bell DR; Thompson S; Austin CA
    Biochem Soc Trans; 1987 Aug; 15(4):573-5. PubMed ID: 3119389
    [No Abstract]   [Full Text] [Related]  

  • 50. Evidence of binary complex formations between cytochrome P-450, cytochrome b5, and NADPH-cytochrome P-450 reductase of hepatic microsomes.
    Tamburini PP; MacFarquhar S; Schenkman JB
    Biochem Biophys Res Commun; 1986 Jan; 134(2):519-26. PubMed ID: 3080992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation and detoxification metabolism of urban air pollutants 2-nitrobenzanthrone and carcinogenic 3-nitrobenzanthrone by rat and mouse hepatic microsomes.
    Stiborova M; Cechova T; Borek-Dohalska L; Moserova M; Frei E; Schmeiser HH; Paca J; Arlt VM
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():8-15. PubMed ID: 23353838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of dexamethasone with acetylsalicylic acid in mice.
    Tantcheva L; Stoytchev T; Rangelova D
    Methods Find Exp Clin Pharmacol; 1997; 19(6):387-94. PubMed ID: 9385588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Zinc mediates normalization of hepatic drug metabolizing enzymes in chlorpyrifos-induced toxicity.
    Goel A; Dani V; Dhawan DK
    Toxicol Lett; 2007 Feb; 169(1):26-33. PubMed ID: 17194553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A model of cytochrome P-450-centered hepatic dysfunction in drug metabolism induced by cobalt-protoporphyrin administration.
    Muhoberac BB; Hanew T; Halter S; Schenker S
    Biochem Pharmacol; 1989 Nov; 38(22):4103-13. PubMed ID: 2512932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Xenobiotic metabolism in humanized yeast: engineered yeast cells producing human NADPH-cytochrome P-450 reductase, cytochrome b5, epoxide hydrolase and P-450s.
    Urban P; Truan G; Gautier JC; Pompon D
    Biochem Soc Trans; 1993 Nov; 21(4):1028-34. PubMed ID: 8131892
    [No Abstract]   [Full Text] [Related]  

  • 56. Circadian variation of mitochondrial succinic dehydrogenase and microsomal cytochrome P-450 dependent monooxygenase activity in the liver of sexually immature and mature rats.
    Wielgus-Serafińska E; Plewka A; Kamiński M
    J Physiol Pharmacol; 1993 Mar; 44(1):55-63. PubMed ID: 8518425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytochrome b5-mediated redox cycling of estrogen.
    Roy D; Strobel HW; Liehr JG
    Arch Biochem Biophys; 1991 Mar; 285(2):331-8. PubMed ID: 1897935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunochemical studies on the contribution of NADPH cytochrome P-450 reductase to the cytochrome P-450-dependent metabolism of arachidonic acid.
    Schwartzman ML; Pagano PJ; McGiff JC; Abraham NG
    Arch Biochem Biophys; 1987 Feb; 252(2):635-45. PubMed ID: 3101602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of the oral contraceptive, menstranol, on drug-metabolizing enzymes of female rats in thiamin-supplemented and deficiency states.
    Wade AE; Evans JL; Seitz A
    Pharmacology; 1976; 14(2):104-14. PubMed ID: 822434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of NADPH-cytochrome P450 reductase and cytochrome-b5/NADH-b5 reductase in variability of CYP3A activity in human liver microsomes.
    Gan L; von Moltke LL; Trepanier LA; Harmatz JS; Greenblatt DJ; Court MH
    Drug Metab Dispos; 2009 Jan; 37(1):90-6. PubMed ID: 18838505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.